Krebs in der Schwangerschaft: Diagnose, Behandlungsoptionen und Outcome

Das Auftreten von Krebs in der Schwangerschaft ist eine seltene Problematik – die Behandlung stellt jedoch eine interdisziplinäre Herausforderung dar und bedarf einer engen Zusammenarbeit, um eine adäquate Behandlung mit dem geringsten Risiko für die Patientin und das Ungeborene zu gewährleisten. Diese Übersicht thematisiert die Optionen abhängig vom Stadium der Tumorerkrankung und der Dringlichkeit der Therapie in verschiedenen Phasen der Schwangerschaft bis hin zur Geburt.

Schlüsselwörter

Krebs - Chemotherapie - Schwangerschaft - Früherkennung - Therapieauswahl

• Literatur

• 1 de Haan J, Verheecke M, Van Calsteren K. et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol 2018; 19: 337-346
• 2 Walsh EM, O’Kane GM, Cadoo KA. et al. Is chemotherapy always required for cancer in pregnancy? An observational study. Ir J Med Sci 2017; 186: 875-881
• 3 Miyamoto S, Yamada M, Kasai Y. et al. Anticancer drugs during pregnancy. Jpn J Clin Oncol 2016; 46: 795-804
• 4 Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283-291
• 5 Santolaria A, Perales A, Montesinos P. et al. Acute Promyelocytic Leukemia during Pregnancy: A Systematic Review of the Literature. Cancers (Basel) 2020; 12
• 6 van Westrhenen A, Senders JT, Martin E. et al. Clinical challenges of glioma and pregnancy: a systematic review. J Neurooncol 2018; 139: 1-11
• 7 Lindheimer MD, Davison JM, Katz AI. The kidney and hypertension in pregnancy: twenty exciting years. Semin Nephrol 2001; 21: 173-189
• 8 Berveiller P, Selleret L, Mir O. Drug selection and dosing in pregnant cancer patients: insights from clinical pharmacokinetics. Ann Oncol 2014; 25: 1869-1870
• 9 Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997; 74: 207-220
• 10 Esposito S, Tenconi R, Preti V. et al. Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes. Medicine (Baltimore) 2016; 95: e4899
• 11 Anampa J, Makower D, Sparano JA. Progress in adjuvant chemotherapy for breast cancer: an overview. BMC Med 2015; 13: 195
• 12 Lorenzi E, Simonelli M, Persico P. et al. Risks of molecular targeted therapies to fertility and safety during pregnancy: a review of current knowledge and future needs. Expert Opin Drug Saf 2021; 20: 503-521
• 13 Farooq F, Brandt JS, Cardonick E. et al. An International Real-World Analysis of Relapsed/Refractory Lymphoma Occurring During Pregnancy. Blood Adv 2023;
• 14 Maggen C, Dierickx D, Cardonick E. et al. Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy. Br J Haematol 2021; 193: 52-62
• 15 Andrikopoulou A, Korakiti AM, Apostolidou K. et al. Immune checkpoint inhibitor administration during pregnancy: a case series. ESMO Open 2021; 6: 100262
• 16 Salehi I, Porto L, Elser C. et al. Immune Checkpoint Inhibitor Exposure in Pregnancy: A Scoping Review. J Immunother 2022; 45: 231-238
• 17 Kocian P, de Haan J, Cardonick EH. et al. Management and outcome of colorectal cancer during pregnancy: report of 41 cases. Acta Chir Belg 2019; 119: 166-175
• 18 Lishner M, Avivi I, Apperley JF. et al. Hematologic Malignancies in Pregnancy: Management Guidelines From an International Consensus Meeting. J Clin Oncol 2016; 34: 501-508
• 19 Boxer LA, Bolyard AA, Kelley ML. et al. Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia. Obstet Gynecol 2015; 125: 197-203
• 20 Alexander A, Samlowski WE, Grossman D. et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant. J Clin Oncol 2003; 21: 2179-2186